RDHL - What's Going On With Redhill Biopharma Stock? | Benzinga
Redhill Biopharma Ltd. (NASDAQ: RDHL) shares are volatile Wednesday, and the stock is up approximately 700% over the last five days.
What To Know:
On Monday, Redhill Biopharma announced that the FDA had granted five years' market exclusivity for its drug, Talicia, on top of three years' exclusivity granted for the approval of Talicia.
Talicia is a first-line therapy prescribed ...